Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001649904-26-000015

Chief Technical Officer sold 5,079 shares at $119.75 ($608,210)

  • Chief Technical Officer acquired 2,024 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Shulman Joseph · Chief Technical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-13 Exercise or conversion : show line 1 in the form 10b5-1 +2,024 $6.80 $13,763 20,994 D
2026-08-13 Sale : show line 2 in the form 10b5-1 −5,079 $119.75 $608,210 15,915 D
Open-market sales · 5,079 sh · avg $119.75 · $608,210

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-13 Exercise or conversion : show line 3 in the form 10b5-1 Stock Options (Right to Buy) −2,024 5,945 D
Loading xslF345X06/form4.xml…